Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Could SBS-147 become a credible challenger to opioid-based pain management pathways? Could SBS-147 challenge opioid-based pain treatment pathways? Read how Sparian Biosciences’ Phase 1 launch could reshape the non-opioid market. bySoujanya RaviApril 12, 2026